Parabilis Medicines, Inc. Common Stock (PBLS) is a publicly traded the market company. As of November 5, 2026, PBLS trades at $27.88 with a market cap of $3.75B and a P/E ratio of -12.68. PBLS moved -8.20% today. Year to date, PBLS is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $22.66 to $42.49. Analyst consensus is strong buy with an average price target of $41.75. Rallies surfaces PBLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover PBLS: 0 strong buy, 5 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $41.75.
| Metric | Value |
|---|---|
| Price | $27.88 |
| Market Cap | $3.75B |
| P/E Ratio | -12.68 |
| EPS | $-2.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.49 |
| 52-Week Low | $22.66 |
| Volume | 812.84K |
| Avg Volume | 0 |
| Revenue (TTM) | $148.00K |
| Net Income | $-52.46M |
| Gross Margin | 0.00% |
5 analysts cover PBLS: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.75.